Metaxalone Tablet
Product Images NDC 80425-0131

4 FDA label images from Advanced Rx Pharmacy Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 80425-0131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

Figure 1
A line graph showing mean concentrations of Metaxalone over 12 hours following an 800 mg dose under fasted and fed conditions. The y-axis represents concentration (ng/mL) while the x-axis represents time in hours. Two curves demonstrate higher Metaxalone concentrations and prolonged presence under fed conditions compared to fasted conditions.*
FDA Label Image

Metaxalone 800mg Tab Qty 60 Ndc 80425 0131

Metaxalone 800mg Tab Qty 60 Ndc 80425 0131
Metaxalone 800 mg oral tablet packaging label by Advanced Rx Pharmacy of Tennessee, LLC. The label includes the product name Metaxalone 800 mg TAB #60, a NDC number 80425-0131-02, lot number 60MTX8001222, expiration date 12/31/2022, and storage instructions to keep at room temperature 20°-25°C (68°-77°F). The label references Skelaxin for comparison and lists manufacturers ACTAVIS/TEVA.*
FDA Label Image

Metaxalone 800mg Tab Qty 90 Ndc 80425 0131

Metaxalone 800mg Tab Qty 90 Ndc 80425 0131
Label for Metaxalone 800 mg oral tablets by Advanced Rx Pharmacy of Tennessee, LLC, listing NDC 80425-0131-01. The label includes storage instructions (20°-25°C) and expiration date 12/31/2022. It references source NDC 00591-2341-01 and manufacturers Actavis/Teva.*
FDA Label Image

Structure

Structure
Chemical structure of Metaxalone, showing its molecular arrangement with a benzene ring substituted with two methyl groups, an ether linkage, and a morpholine-2,5-dione moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.